Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Antimicrobial Agents and Chemotherapy
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Epidemiology and Surveillance

Genetic Features of blaNDM-1-Positive Enterobacteriaceae

Laurent Poirel, Laurent Dortet, Sandrine Bernabeu, Patrice Nordmann
Laurent Poirel
Service de Bactériologie-Virologie, INSERM U914 Emerging Resistance to Antibiotics, Hôpital de Bicêtre, Assistance Publique/Hôpitaux de Paris, Faculté de Médecine Paris-Sud, Université Paris XI, Le-Kremlin-Bicêtre, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laurent Dortet
Service de Bactériologie-Virologie, INSERM U914 Emerging Resistance to Antibiotics, Hôpital de Bicêtre, Assistance Publique/Hôpitaux de Paris, Faculté de Médecine Paris-Sud, Université Paris XI, Le-Kremlin-Bicêtre, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sandrine Bernabeu
Service de Bactériologie-Virologie, INSERM U914 Emerging Resistance to Antibiotics, Hôpital de Bicêtre, Assistance Publique/Hôpitaux de Paris, Faculté de Médecine Paris-Sud, Université Paris XI, Le-Kremlin-Bicêtre, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patrice Nordmann
Service de Bactériologie-Virologie, INSERM U914 Emerging Resistance to Antibiotics, Hôpital de Bicêtre, Assistance Publique/Hôpitaux de Paris, Faculté de Médecine Paris-Sud, Université Paris XI, Le-Kremlin-Bicêtre, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: nordmann.patrice@bct.aphp.fr
DOI: 10.1128/AAC.00585-11
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

Genetic features associated with the blaNDM-1 gene were investigated in 6 Escherichia coli, 7 Klebsiella pneumoniae, 1 Citrobacter freundii, 1 Proteus mirabilis, and 1 Providencia stuartii isolate of worldwide origin. Clonal diversity was observed for both E. coli and K. pneumoniae. The blaNDM-1 gene was carried by different plasmid types (IncA/C, IncF, IncL/M, or untypeable) and was likely chromosome borne in two isolates. The blaNDM-1 plasmids coharbored a variety of resistance determinants, including β-lactamase genes, quinolone resistance genes, and 16S RNA methylase genes.

TEXT

Recent reports showed that the plasmid-mediated blaNDM-1 gene encoding the metallo-β-lactamase (MBL) NDM-1 is spreading worldwide, mainly in members of the Enterobacteriaceae originating primarily from the Indian subcontinent (10, 14, 28).

Our aim was to compare the genetic features of NDM-1-producing strains recovered from unrelated countries by analyzing a collection of 16 multidrug-resistant and blaNDM-1-pos-itive enterobacterial isolates (Table 1). The genetic context and plasmid support of the blaNDM-1 gene were investigated, and the main broad-spectrum resistance determinants to non-β-lactam antibiotics were also examined.

View this table:
  • View inline
  • View popup
Table 1.

Genetic features associated with the blaNDM-1 gene

Population structure of NDM-1 producers.Multilocus sequence typing (MLST) was performed as described previously (7, 26) for Escherichia coli and Klebsiella pneumoniae isolates. Five MLST types were identified among the six E. coli isolates, showing that diverse NDM-1-positive clones were circulating (Table 1). Only one out of the six E. coli isolates was an ST131 type, which is the major clone carrying the extended-spectrum ß-lactamase (ESBL) blaCTX-M-15 gene worldwide (4, 13). Similarly, four MLST types were identified among the seven K. pneumoniae isolates (Table 1). The ST14 type that corresponds to that of the first described NDM-1-producing K. pneumoniae isolate recovered in Sweden from an Indian patient (29) was also identified in three isolates, one each from India, Oman, and Kenya. Pulsed-field gel electrophoresis (PFGE) performed as described previously (4) and interpreted according to the criteria of Tenover et al. (27) showed that isolates from Oman, Kenya, and Sweden were clonally related, whereas the remaining ST14 isolate from India had a significantly different pattern (data not shown). In addition, the two ST147 K. pneumoniae isolates, one each from Switzerland and Iraq, were clonally related. The ST258 type known to carry the blaKPC genes worldwide was not identified here (5).

Just by analyzing strains isolated in India or elsewhere but from patients previously hospitalized on the Indian subcontinent, a large variety of ST types was evidenced, emphasizing the diversity of clones carrying the blaNDM-1 gene. This interesting feature is highlighted in Fig. 1, which includes data from our study but also from other studies in which information about MLST typing was available.

Fig. 1.
  • Open in new tab
  • Download powerpoint
Fig. 1.

Worldwide distribution of NDM-1-producing E. coli and K. pneumoniae isolates. The color codes for the isolates are used to indicate the country where the isolate was recovered. Circles, E. coli; stars, K. pneumoniae. Isolates include those identified in the present study (underlined STs) and strains reported in other studies only when the results of MLST typing were available (6, 11, 15–20, 22, 25, 29).

Antibiotic resistance gene content.PCR was used with primers specific for many resistance genes (Table 2) (1, 3, 23). Most of the blaNDM-1-positive isolates coharbored an ESBL gene, mostly the blaCTX-M-15 gene. The blaTEM-1, blaOXA-1, and blaOXA-10 genes were also frequently detected. Cooccurrence of 16S RNA methylase genes encoding broad-spectrum aminoglycoside resistance was often observed, being of different types (armA, rmtA, rmtB, and rmtC). Among the plasmid-mediated quinolone resistance genes, a qnr-type gene was identified in a few cases, as well as the aac(6′)-Ib-cr gene encoding reduced susceptibility to ciprofloxacin and the qepA efflux pump-encoding gene (Table 1). These results indicate that the NDM-1 producers have gathered uncommon and unrelated broad-spectrum resistance genes, suggesting that they have been selected by broad-spectrum antibiotics. These high levels of resistance did not result from single genetic events.

View this table:
  • View inline
  • View popup
Table 2.

Oligonucleotides used in this study

Genetic support of the blaNDM-1 gene.Mating-out assays performed as described previously (24) with NDM-1 producers as the donors and azide-resistant E. coli J53 as the recipient and using a selection based on cefoxitin (10 μg/ml) (cefoxitin being a substrate of NDM-1 but not of ESBLs) and azide (100 μg/ml) produced transconjugants except for two strains (Table 1). Analysis of plasmid DNAs as reported previously (9) identified a variety of plasmid supports in those transconjugants according to their sizes, which ranged from 35 to 170 kb (Table 1). No blaNDM-1-carrying plasmid was identified in two isolates (E. coli RKI and Providencia stuartii PS1), suggesting the presence of a chromosomal support. Some transconjugants possessed two plasmids, indicating that several blaNDM-1-positive plasmids were likely not self-conjugative and required a helper plasmid for their mobilization. This was confirmed by electrotransformation experiments using plasmid extracts from donors and electrocompetent E. coli TOP10 as the recipient and a selection based on cefoxitin (10 μg/ml). Transformants were obtained for all strains except for E. coli RKI and P. stuartii PS1.

Plasmid incompatility groups were then assigned by using the PCR-based replicon typing method (2), identifying a variety of plasmid scaffolds carrying the blaNDM-1 gene. Our data indicate that its current spread is therefore not related to a single plasmid. Several plasmids were of narrow host range, such as the IncF plasmids, and thus able to disseminate among Enterobacteriaceae only; others were of broad host range, such as the IncA/C types, able to also replicate in Acinetobacter and Pseudomonas species.

PCR mapping of the blaNDM-1-surrounding sequences.We previously identified insertion sequences (IS) located on both extremities of the blaNDM-1 gene in E. coli 271 (19). In that isolate, the blaNDM-1 gene was bracketed by ISEc33 and ISSen4 (19) (Fig. 2). Further analysis performed on that isolate identified that part of ISAba125, an IS element that had been previously identified in blaNDM-1-negative Acinetobacter strains (8, 12) was present upstream of blaNDM-1. Primers specific for ISAba125 were designed, targeting its right end comprising the promoter sequence as well as its left end (Table 2; Fig. 2). We also identified a gene we named bleMBL which encoded a 122-amino-acid-long protein and conferred putative resistance to bleomycin immediately downstream of the blaNDM-1 gene in E. coli GUE. Thus, primers specific for this bleMBL gene were also designed (Table 2), and their locations are indicated in Fig. 2.

Fig. 2.
  • Open in new tab
  • Download powerpoint
Fig. 2.

Schematic map of blaNDM-1-associated genetic structures identified among enterobacterial isolates. (A) Structure identified from E. coli 271 in which the ISEc33 and ISSen4 elements have been identified on both ends of the blaNDM-1 gene (19); (B)structure in which ISAba125 is present as a truncated element, but without ISEc33 (K. pneumoniae Kp7 and 601); (C) structure in which ISAba125 is present as a full element and the bleMBL gene is present (E. coli GUE, I5, RKI, and 5649; K. pneumoniae K2, IBN, and 419; Citrobacter freundii STE, and P. stuartii PS1); (D) structure initially identified in K. pneumoniae 05-506 (29); (E) structure in which ISAba125 is present as a full element but the bleomycin resistance bleMBL gene is absent or truncated (E. coli RIC, K. pneumoniae 6642 and 6759, Proteus mirabilis 7892). Genes and their corresponding transcription orientations are indicated by horizontal arrows. Positions of the primers as well as the blaNDM-1 promoter are indicated.

Genetic structures surrounding the blaNDM-1 gene showed that at least a remnant of insertion sequence ISAba125 was systematically present upstream of the blaNDM-1 gene. The entire ISAba125 element was identified upstream of the blaNDM-1 gene in most isolates, except in three cases (E. coli 271 and K. pneumoniae Kp7 and 601) (Table 1). However, the ISEc33 identified in E. coli 271 was absent in K. pneumoniae Kp7 and 601 (Fig. 2). These results suggest that ISAba125 was likely at the origin of the original mobilization of the blaNDM-1 from its progenitor.

Downstream of the blaNDM-1 gene, the bleMBL gene was quite systematically identified in most isolates; it was not amplified by PCR in four isolates only (Table 1). Those isolates were from France and Switzerland, and the source of contamination could be traced back to India, Pakistan, and Serbia (21; this study). This would suggest that an ISAba125-related initial mobilization mechanism had been responsible for an acquisition en bloc of both the blaNDM-1 and bleMBL genes. Therefore, our working hypothesis is that both the blaNDM-1 and the bleMBL gene originated from the same progenitor.

Concluding remarks.This study showed that almost all NDM-1 producers coexpressed plasmid-mediated AmpCs or ESBLs, which may have initially contributed to the frequent use of carbapenems for treating related infections. As opposed to what has been observed for CTX-M-15 or KPC-2, NDM-1 is not associated with certain clones, plasmids, or transposons. The only common features identified here correspond to an ISAba125 element and a bleMBL gene identified upstream and downstream, respectively, of the blaNDM-1 gene. The diversity of genetic features associated with the blaNDM-1 gene may explain its current high rate of spread worldwide.

ACKNOWLEDGMENTS

The research leading to these results received funding from the INSERM (U914), Paris, France, and the European Community's Seventh Framework Programme FP7/2007-2013 under grant agreement no. 241742 (TEMPOtest-QC).

FOOTNOTES

    • Received 27 April 2011.
    • Returned for modification 4 June 2011.
    • Accepted 12 August 2011.
    • Accepted manuscript posted online 22 August 2011.
  • Copyright © 2011, American Society for Microbiology. All Rights Reserved.

REFERENCES

  1. 1.↵
    1. Berçot B.,
    2. Poirel L.,
    3. Nordmann P.
    . Updated multiplex PCR for detection of 16S rRNA methylases; high prevalence among NDM-1 producers. Diagn. Microbiol. Infect. Dis., in press.
  2. 2.↵
    1. Carattoli A.,
    2. et al
    . 2005. Identification of plasmids by PCR-based replicon typing. J. Microbiol. Methods 63:219–228.
    OpenUrlCrossRefPubMedWeb of Science
  3. 3.↵
    1. Cattoir V.,
    2. Poirel L.,
    3. Rotimi V.,
    4. Soussy C.-J.,
    5. Nordmann P.
    . 2007. Multiplex PCR for detection of plasmid-mediated quinolone resistance qnr genes in ESBL-producing enterobacterial isolates. J. Antimicrob. Chemother. 60:394–397.
    OpenUrlCrossRefPubMedWeb of Science
  4. 4.↵
    1. Coque T. M.,
    2. et al
    . 2008. Dissemination of clonally related Escherichia coli strains expressing extended-spectrum β-lactamase CTX-M-15. Emerg. Infect. Dis. 14:195–200.
    OpenUrlCrossRefPubMedWeb of Science
  5. 5.↵
    1. Cuzon G.,
    2. et al
    . 2010. Worldwide diversity of Klebsiella pneumoniae that produce β-lactamase blaKPC-2 gene. Emerg. Infect. Dis. 16:1349–1356.
    OpenUrlCrossRefPubMedWeb of Science
  6. 6.↵
    1. D'Andrea M. M.,
    2. et al
    . 2011. Persistent carriage and infection by multidrug-resistant Escherichia coli ST405 producing NDM-1 carbapenemase: report on the first Italian cases. J. Clin. Microbiol. 49:2755–2758.
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    1. Diancourt L.,
    2. Passet V.,
    3. Verhoef J.,
    4. Grimont P. A.,
    5. Brisse S.
    . 2005. Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates. J. Clin. Microbiol. 43:4178–4182.
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    1. Evans B. A.,
    2. Hamouda A.,
    3. Towner K. J.,
    4. Amyes S. G.
    . 2010. Novel genetic context of multiple blaOXA-58 genes in Acinetobacter genospecies 3. J. Antimicrob. Chemother. 65:1586–1588.
    OpenUrlCrossRefPubMedWeb of Science
  9. 9.↵
    1. Kieser T.
    1984. Factors affecting the isolation of CCC DNA from Streptomyces lividans and Escherichia coli. Plasmid 12:19–36.
    OpenUrlCrossRefPubMedWeb of Science
  10. 10.↵
    1. Kumarasamy K. K.,
    2. et al
    . 2010. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect. Dis. 10:597–602.
    OpenUrlCrossRefPubMedWeb of Science
  11. 11.↵
    1. Mushtaq S.,
    2. et al
    . 2011. Phylogenetic diversity of Escherichia coli strains producing NDM-type carbapenemases. J. Antimicrob. Chemother. 66:2002–2005.
    OpenUrlCrossRefPubMedWeb of Science
  12. 12.↵
    1. Mussi M. A.,
    2. Limansky A. S.,
    3. Viale A. M.
    . 2005. Acquisition of resistance to carbapenems in multidrug-resistant clinical strains of Acinetobacter baumannii: natural insertional inactivation of a gene encoding a member of a novel family of β-barrel outer membrane proteins. Antimicrob. Agents Chemother. 49:1432–1440.
    OpenUrlAbstract/FREE Full Text
  13. 13.↵
    1. Nicolas-Chanoine M. H.,
    2. et al
    . 2008. Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J. Antimicrob. Chemother. 61:273–281.
    OpenUrlCrossRefPubMedWeb of Science
  14. 14.↵
    1. Nordmann P.,
    2. Poirel L.,
    3. Toleman M. A.,
    4. Walsh T. R.
    . 2011. Does broad-spectrum β-lactam resistance due to NDM-1 herald the end of the antibiotic era for treatment of infections caused by Gram-negatives? J. Antimicrob. Chemother. 66:689–692.
    OpenUrlCrossRefPubMedWeb of Science
  15. 15.↵
    1. Pfeifer Y.,
    2. et al
    . 2011. NDM-1-producing E. coli in Germany. Antimicrob. Agents Chemother. 55:1318–1319.
    OpenUrlFREE Full Text
  16. 16.↵
    1. Poirel L.,
    2. Al Maskari Z.,
    3. Al Rashdi F.,
    4. Bernabeu S.,
    5. Nordmann P.
    . 2011. NDM-1-producing Klebsiella pneumoniae isolated in the Sultanate of Oman. J. Antimicrob. Chemother. 55:304–306.
    OpenUrl
  17. 17.↵
    1. Poirel L.,
    2. Fortineau N.,
    3. Nordmann P.
    . 2011. International transfer of NDM-1-producing Klebsiella pneumoniae from Iraq to France. Antimicrob. Agents Chemother. 55:1821–1822.
    OpenUrlFREE Full Text
  18. 18.↵
    1. Poirel L.,
    2. Hombrouck-Alet C.,
    3. Freneaux C.,
    4. Bernabeu S.,
    5. Nordmann P.
    . 2010. Global spread of New Dehli metallo-β-lactamase 1. Lancet Infect. Dis. 10:832.
    OpenUrlCrossRefPubMedWeb of Science
  19. 19.↵
    1. Poirel L.,
    2. Lagrutta E.,
    3. Taylor P.,
    4. Pham J.,
    5. Nordmann P.
    . 2010. Emergence of metallo-β-lactamase NDM-1-producing multidrug-resistant Escherichia coli in Australia. Antimicrob. Agents Chemother. 54:4914–4916.
    OpenUrlAbstract/FREE Full Text
  20. 20.↵
    1. Poirel L.,
    2. Revathi G.,
    3. Bernabeu S.,
    4. Nordmann P.
    . 2011. Detection of NDM-1-producing Klebsiella pneumoniae in Kenya. Antimicrob. Agents Chemother. 55:934–936.
    OpenUrlAbstract/FREE Full Text
  21. 21.↵
    1. Poirel L.,
    2. et al
    . 2011. Extremely drug-resistant Citrobacter freundii identified in a patient returning from India and producing NDM-1 and other carbapenemases. Antimicrob. Agents Chemother. 55:447–448.
    OpenUrlFREE Full Text
  22. 22.↵
    1. Poirel L.,
    2. et al
    . 2011. Molecular analysis of NDM-1-producing enterobacterial isolates from Geneva, Switzerland. J. Antimicrob. Chemother. 66:1730–1733.
    OpenUrlCrossRefPubMedWeb of Science
  23. 23.↵
    1. Poirel L.,
    2. Walsh T. R.,
    3. Cuvillier V.,
    4. Nordmann P.
    . 2011. Multiplex PCR for detection of acquired carbapenemase genes. Diagn. Microbiol. Infect. Dis. 70:119–123.
    OpenUrlCrossRefPubMed
  24. 24.↵
    1. Rodriguez-Martinez J. M.,
    2. Nordmann P.,
    3. Fortineau N.,
    4. Poirel L.
    . 2010. VIM-19, a metallo-β-lactamase with increased carbapenemase activity from Escherichia coli and Klebsiella pneumoniae. Antimicrob. Agents Chemother. 54:471–476.
    OpenUrlAbstract/FREE Full Text
  25. 25.↵
    1. Solé M.,
    2. et al
    . 2011. First description of an Escherichia coli strain producing NDM-1 carbapenemase in Spain. Antimicrob. Agents Chemother. 55:4402–4404.
    OpenUrlAbstract/FREE Full Text
  26. 26.↵
    1. Tartof S. Y.,
    2. et al
    . 2005. Analysis of a uropathogenic Escherichia coli clonal group by multilocus sequence typing. J. Clin. Microbiol. 43:5860–5864.
    OpenUrlAbstract/FREE Full Text
  27. 27.↵
    1. Tenover F. C.,
    2. et al
    . 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233–2239.
    OpenUrlFREE Full Text
  28. 28.↵
    1. Walsh T. R.,
    2. Weeks J.,
    3. Livermore D. M.,
    4. Toleman M. A.
    . 2011. Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study. Lancet Infect. Dis. 11:355–362.
    OpenUrlCrossRefPubMedWeb of Science
  29. 29.↵
    1. Yong D.,
    2. et al
    . 2009. Characterization of a new metallo-β-lactamase gene, blaNDM-1, and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob. Agents Chemother. 53:5046–5054.
    OpenUrlAbstract/FREE Full Text
View Abstract
PreviousNext
Back to top
Download PDF
Citation Tools
Genetic Features of blaNDM-1-Positive Enterobacteriaceae
Laurent Poirel, Laurent Dortet, Sandrine Bernabeu, Patrice Nordmann
Antimicrobial Agents and Chemotherapy Oct 2011, 55 (11) 5403-5407; DOI: 10.1128/AAC.00585-11

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Antimicrobial Agents and Chemotherapy article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Genetic Features of blaNDM-1-Positive Enterobacteriaceae
(Your Name) has forwarded a page to you from Antimicrobial Agents and Chemotherapy
(Your Name) thought you would be interested in this article in Antimicrobial Agents and Chemotherapy.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Genetic Features of blaNDM-1-Positive Enterobacteriaceae
Laurent Poirel, Laurent Dortet, Sandrine Bernabeu, Patrice Nordmann
Antimicrobial Agents and Chemotherapy Oct 2011, 55 (11) 5403-5407; DOI: 10.1128/AAC.00585-11
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • TEXT
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

About

  • About AAC
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • AAC Podcast
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #AACJournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0066-4804; Online ISSN: 1098-6596